|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1994-4-22
|
|
pubmed:abstractText |
A Phase II study with carboplatin, methotrexate, and vinblastine (CAMV) was conducted with patients who had advanced urothelial cancer to investigate the activity and toxicity of carboplatin when used in combination chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1932-6
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8137220-Adult,
pubmed-meshheading:8137220-Aged,
pubmed-meshheading:8137220-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8137220-Carboplatin,
pubmed-meshheading:8137220-Carcinoma, Squamous Cell,
pubmed-meshheading:8137220-Carcinoma, Transitional Cell,
pubmed-meshheading:8137220-Creatinine,
pubmed-meshheading:8137220-Female,
pubmed-meshheading:8137220-Follow-Up Studies,
pubmed-meshheading:8137220-Humans,
pubmed-meshheading:8137220-Kidney Neoplasms,
pubmed-meshheading:8137220-Kidney Pelvis,
pubmed-meshheading:8137220-Male,
pubmed-meshheading:8137220-Methotrexate,
pubmed-meshheading:8137220-Middle Aged,
pubmed-meshheading:8137220-Neoplasm Staging,
pubmed-meshheading:8137220-Remission Induction,
pubmed-meshheading:8137220-Urinary Bladder Neoplasms,
pubmed-meshheading:8137220-Vinblastine
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial.
|
|
pubmed:affiliation |
Department of Medical Oncology 2, National Institute for Cancer Research, Genoa, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
